Skip to content
   
The productivity enhancer and science driver
Jan Lundberg and Barry Furr

Once again, two of AstraZeneca’s scientific leaders have been recognised in the PharmaVOICE 100.

Jan Lundberg, Executive VP Discovery Research, and Barry Furr, Former Chief Scientist and Head Project Evaluation Group, have the distinction of being named two of the top 100 most influential members of the global life sciences community.

Nominated by readers of PharmaVOICE, a leading industry trade publication, the honorees were selected based on their ability to inspire, motivate and influence their areas of expertise.

Read more about Professor Jan Lundberg

Read more about Professor Barry Furr

Published August 2006

AstraZeneca websites
Search
Related articles